Resistant Hypertension clinical trials

Explore recruiting resistant hypertension clinical trials.

Recruiting resistant hypertension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resistant Hypertension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A three-way cross-over phase IIa trial using L-citrulline and folic acid in combination with vericiguat and tadalafil in patients with treatment-resistant hypertension

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Lorundrostat in Subjects with Uncontrolled and Resistant Hypertension

Poland, France, Spain, Italy, Netherlands, Bulgaria +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants with Resistant Hypertension.

Bulgaria, Spain, Slovakia, Germany, Hungary, Greece +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Semaglutide for people with obesity and resistant hypertension (SUPPORT): a pilot, randomized, parallel-group, integrated, multicentre clinical trial.

Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension

Netherlands, Bulgaria, Denmark, Czechia, Hungary, France +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A trial to learn how baxdrostat affects the heartbeat in healthy participants

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Resistant Hypertension trials by city

Resistant Hypertension in Toronto Resistant Hypertension in Vancouver Resistant Hypertension in Montreal Resistant Hypertension in Calgary Resistant Hypertension in Edmonton Resistant Hypertension in Ottawa Resistant Hypertension in Winnipeg Resistant Hypertension in Quebec City Resistant Hypertension in Hamilton Resistant Hypertension in Kitchener Resistant Hypertension in London Resistant Hypertension in Halifax Resistant Hypertension in New York Resistant Hypertension in Los Angeles Resistant Hypertension in Chicago Resistant Hypertension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease